Challenges for Treatment Trials of Inclusion Body Myositis

Neurology. 2021 Mar 23;96(12):555-556. doi: 10.1212/WNL.0000000000011628. Epub 2021 Feb 17.

Authors

Bhaskar Roy¹, Robert C Griggs²

Affiliations

¹ From the Yale University School of Medicine (B.R.), New Haven, CT; and University of Rochester Medical Center (R.C.G.), NY. bhaskar.roy@yale.edu.
² From the Yale University School of Medicine (B.R.), New Haven, CT; and University of Rochester Medical Center (R.C.G.), NY.

PMID: 33597288
DOI: 10.1212/WNL.0000000000011628

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Humans
Muscle, Skeletal
Myositis, Inclusion Body*

Substances

Antibodies, Monoclonal, Humanized
bimagrumab